Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double‐Blind, Placebo‐Controlled REGAIN, and Pooled EVOLVE‐1 and EVOLVE‐2 Studies

OBJECTIVE: This post hoc analysis evaluated the efficacy of galcanezumab for the prevention of migraine in patients with and without comorbid anxiety and/or depression. BACKGROUND: Patients with migraine have a higher risk of anxiety and/or depression. Given the high prevalence of psychiatric sympto...

Descripción completa

Detalles Bibliográficos
Autores principales: Smitherman, Todd A., Tietjen, Gretchen E., Schuh, Kory, Skljarevski, Vladimir, Lipsius, Sarah, D’Souza, Deborah N., Pearlman, Eric M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Submissions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756873/
https://www.ncbi.nlm.nih.gov/pubmed/33063862
http://dx.doi.org/10.1111/head.13970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756873/
https://www.ncbi.nlm.nih.gov/pubmed/33063862
http://dx.doi.org/10.1111/head.13970

Ejemplares similares